Henry Schein, Inc.
General ticker "HSIC" information:
- Sector: Health Care
- Industry: Medical - Distribution
- Capitalization: $8.6B (TTM average)
Henry Schein, Inc. follows the US Stock Market performance with the rate: 41.9%.
Estimated limits based on current volatility of 1.2%: low 79.68$, high 81.69$
Factors to consider:
- Company included in S&P500 list
- Total employees count: 25000 (0.0%) as of 2024
- US accounted for 69.5% of revenue in the fiscal year ended 2024-12-28
- Top business risk factors: Cybersecurity threats, Pandemic risks, Activist investors, Regulatory and compliance, Geopolitical risks
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-27 to 2027-12-27
- 2025-12-27 to 2026-12-27 estimated range: [63.42$, 88.64$]
- 2026-12-27 to 2027-12-27 estimated range: [63.88$, 90.11$]
Financial Metrics affecting the HSIC estimates:
- Negative: with PPE of 15.5 at the end of fiscal year the price was high
- Positive: -4.75 < Operating profit margin, % of 5.75
- Positive: 6.64 < Operating cash flow per share per price, % of 7.67
- Positive: -0.01 < Industry operating cash flow per share per price (median), % of 5.39
- Negative: 0.73 < Interest expense per share per price, % of 1.62
- Positive: Inventory ratio change, % of 0.69 <= 0.80
- Positive: 19.40 < Shareholder equity ratio, % of 28.93 <= 42.68
- Positive: Industry inventory ratio change (median), % of 0.02 <= 0.31
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 3.60
- Negative: Industry earnings per price (median), % of 3.07 <= 4.49
Short-term HSIC quotes
Long-term HSIC plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-28 | 2025-12-27 |
|---|---|---|---|
| Operating Revenue | $12,339.00MM | $12,673.00MM | $13,184.00MM |
| Operating Expenses | $11,625.00MM | $12,052.00MM | $12,426.00MM |
| Operating Income | $714.00MM | $621.00MM | $758.00MM |
| Non-Operating Income | $-158.00MM | $-108.00MM | $-213.00MM |
| Interest Expense | $87.00MM | $131.00MM | $150.00MM |
| Income(Loss) | $556.00MM | $513.00MM | $545.00MM |
| Taxes | $120.00MM | $128.00MM | $126.00MM |
| Other Income(Loss) | $0.00MM | $13.00MM | $0.00MM |
| Profit(Loss)* | $416.00MM | $390.00MM | $398.00MM |
| Stockholders Equity | $3,655.00MM | $3,393.00MM | $3,245.00MM |
| Inventory | $1,815.00MM | $1,810.00MM | $2,002.00MM |
| Assets | $10,573.00MM | $10,218.00MM | $11,215.00MM |
| Operating Cash Flow | $500.00MM | $848.00MM | $712.00MM |
| Capital expenditure | $147.00MM | $187.00MM | $139.00MM |
| Investing Cash Flow | $-1,135.00MM | $-430.00MM | $-477.00MM |
| Financing Cash Flow | $701.00MM | $-510.00MM | $-111.00MM |
| Earnings Per Share** | $3.18 | $3.08 | $3.29 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.